Cargando…
Ceftriaxone-Induced Reversible Agranulocytosis: A Case Report and Review of Drug-Induced Agranulocytosis
In the modern era of medicine, agranulocytosis is a rare occurrence. Despite significant improvement in patient survival, it still carries significant mortality. Agranulocytosis is most commonly caused by chemotherapeutic agents and numerous non-chemo drugs. As it can develop anytime during treatmen...
Autores principales: | Munir, Farrukh, Javaid, Hafiza Wajeeha, Rana, Muhammad Burhan Majeed, Shaukat, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012477/ https://www.ncbi.nlm.nih.gov/pubmed/35449634 http://dx.doi.org/10.7759/cureus.23226 |
Ejemplares similares
-
Agranulocytosis Following COVID-19 Recovery
por: Lutfi, Forat, et al.
Publicado: (2020) -
Ceftriaxone: Agranulocytosis: case report
Publicado: (2021) -
A Case Report on Metamizole-Induced Agranulocytosis: Is the Benefit Worth the Risk?
por: Carvalho, Rita, et al.
Publicado: (2023) -
Austrian syndrome, ceftriaxone-induced agranulocytosis and COVID-19
por: McCulloch, James Edward, et al.
Publicado: (2021) -
Relapsing Extramedullary Multiple Myeloma Presenting As Acute Liver Failure
por: Javaid, Hafiza Wajeeha, et al.
Publicado: (2021)